Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prednisolone versus hydrocortisone replacement in adrenal insufficiency
ISRCTN41325341Phase 3Completed
- Sponsor
- Imperial College London
- Start
- Feb 2019
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
01
Overview
Phase 3, randomised, open-label trial of prednisolone and hydrocortisone in hypoadrenocorticism (2 arms), sponsored by Imperial College London. Primary endpoint: Osteocalcin concentration. Started Feb 2019; status: completed.
02
Drugs
prednisolonehydrocortisone
03
Conditions
hypoadrenocorticism
Beyond the preview
Go deeper on ISRCTN41325341.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN41325341.